Discover 3,494 paid clinical trials in Torrance, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,494
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
for
Recurrent or Metastatic Solid Tumors
Location: Newport Beach CA, Las Vegas NV, Nashville TN,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07015697
Phase 1, Recruiting
PrEP Talk: PrEP Uptake With Young Black MSM and Their Close Friends
for
HIV Negative and Not Yet on PrEP
Location: Los Angeles CA
Sponsor: California State University, Dominguez Hills
Sex: All
Age: 18 - 29
Code: NCT04601649
Early Phase 1, Recruiting
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Duarte CA, Irvine CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06910761
Phase 2, Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Los Angeles CA, Bakersfield CA, Surprise AZ, Peoria AZ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase 3, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Los Angeles CA, Duarte CA, La Jolla CA, Phoenix AZ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: San Diego CA, Murrieta CA, Rancho Mirage CA,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT06995677
Phase 2, Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
for
Alzheimer Disease
Location: Anaheim CA, Pomona CA, Las Vegas NV, Walnut Creek CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011732
Phase 3, Recruiting
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Duarte CA, Palo Alto CA, Portland OR, Seattle WA,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 18 - 66
Code: NCT06859424
Phase 2, Recruiting
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Los Angeles CA, Newport Beach CA, Houston TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05372640
Phase 1, Recruiting
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
for
Soft-tissue Sarcoma, Triple Negative Breast Cancer,
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT07064018
Phase 1, Phase 2, Recruiting
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
for
Advanced Alveolar Soft Part Sarcoma,
Location: Los Angeles CA, Oklahoma City OK, Houston TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05333458
Phase 2, Recruiting
Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department
for
Opioid Use Disorder
Location: Sylmar CA, El Centro CA, Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT06961058
Recruiting
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
for
Lumbar Spinal Stenosis, Cardiac Amyloidosis,
Location: Beverly Hills CA, Cleveland OH, New York NY, Boston MA
Sponsor: Columbia University
Sex: All
Age: 50+
Code: NCT06034405
Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Los Angeles CA, La Jolla CA, Salt Lake City UT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05896839
Phase 1, Phase 2, Recruiting
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Duarte CA, La Jolla CA, Las Vegas NV,
Sponsor: NiKang Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07029399
Phase 1, Recruiting
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
for
SLE (Systemic Lupus), RA - Rheumatoid Arthritis
Location: Beverly Hills CA, Monterey Park CA, Tujunga CA,
Sponsor: Neutrolis
Sex: All
Age: 18 - 70+
Code: NCT07237659
Phase 1, Recruiting
Diagnosing Epilepsy To EffeCT Change
for
Epilepsy, Epilepsy (Treatment Refractory)
Location: Irvine CA, Palo Alto CA, Phoenix AZ, Billings MT,
Sponsor: Epiminder America, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07110337
Recruiting
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
for
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy,
Location: Los Angeles CA, Murray UT, El Paso TX
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07226986
Phase 1, Phase 2, Recruiting
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment